Summary
This prediction ended on 03.02.17 with a price of €103.45. The SELL prediction by mohabbatein finished with a performance of 20.07%. mohabbatein has 50% into this predictionBayer is a multinational pharmaceutical and life sciences company headquartered in Germany. The company was founded in 1863 and has since grown to become a global leader in the fields of pharmaceuticals, agriculture, and consumer health. Bayer is listed on the Frankfurt Stock Exchange and also trades over-the-counter in the United States under the ticker symbol BAYZF. The company's products include prescription drugs, over-the-counter medicines, and agrochemicals, and it operates in more than 90 countries around the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Bayer AG | 4.521% | 4.521% | -51.338% | -47.179% |
| iShares Core DAX® | 2.831% | 1.236% | 14.788% | 17.647% |
| iShares Nasdaq 100 | 2.918% | 0.640% | 40.290% | 50.762% |
| iShares Nikkei 225® | 2.007% | -2.135% | 19.861% | 4.937% |
| iShares S&P 500 | 2.257% | 0.451% | 30.090% | 43.940% |
Comments by mohabbatein for this prediction
In the thread Bayer AG diskutieren
mohabbatein stimmt dem Crowdsentiment von 'Buy' nicht zu
mohabbatein stimmt am 30.05.2016 dem Buy-Crowdsentiment mit dem Kursziel 111.26€ nicht zu.
Sollte, wie allseits bereits gemunkelt wird, Bayer sein Gebot für Monsanto zeitnah von 122,- auf 130,- Dollar erhöhen, wird der Kurs nochmals in die Knie gehen.
SELL, bis mehr Klarheit vorhanden ist.